ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2108147
CHEMBL2108147
Compound Name STREPTOKINASE
ChEMBL Synonyms KABIKINASE | STREPTASE | STREPTOKINASE
Max Phase 4 (Approved)
Trade Names STREPTASE | KABIKINASE

Sources

  • British National Formulary
  • Manually Added Drugs
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL2108147 compound icon
Drug Type:Enzyme Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:N Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Plasminogen activator Plasminogen PubMed PubMed PubMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Myocardial InfarctionD009203EFO:0000612myocardial infarction3ClinicalTrials
ThrombosisD013927HP:0004419Recurrent thrombophlebitis4ATC
Venous ThrombosisD020246HP:0004936Venous thrombosis3ClinicalTrials

Clinical Data

ClinicalTrials.gov STREPTOKINASE
The Cochrane Collaboration STREPTOKINASE

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Compound Cross References

ATC B - BLOOD AND BLOOD FORMING ORGANS
B01 - ANTITHROMBOTIC AGENTS
B01A - ANTITHROMBOTIC AGENTS
B01AD - Enzymes
B01AD01 - streptokinase

B - BLOOD AND BLOOD FORMING ORGANS
B06 - OTHER HEMATOLOGICAL AGENTS
B06A - OTHER HEMATOLOGICAL AGENTS
B06AA - Enzymes
B06AA55 - streptokinase, combinations

ChemSpider ChemSpider Identifier not yet assigned
spacer
spacer